TW282402B - - Google Patents

Info

Publication number
TW282402B
TW282402B TW81101910A TW81101910A TW282402B TW 282402 B TW282402 B TW 282402B TW 81101910 A TW81101910 A TW 81101910A TW 81101910 A TW81101910 A TW 81101910A TW 282402 B TW282402 B TW 282402B
Authority
TW
Taiwan
Application number
TW81101910A
Other languages
Chinese (zh)
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/774,411 external-priority patent/US5321008A/en
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Application granted granted Critical
Publication of TW282402B publication Critical patent/TW282402B/zh

Links

TW81101910A 1991-10-10 1992-03-13 TW282402B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/774,411 US5321008A (en) 1991-01-10 1991-10-10 Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions

Publications (1)

Publication Number Publication Date
TW282402B true TW282402B (fr) 1996-08-01

Family

ID=51397681

Family Applications (1)

Application Number Title Priority Date Filing Date
TW81101910A TW282402B (fr) 1991-10-10 1992-03-13

Country Status (1)

Country Link
TW (1) TW282402B (fr)

Similar Documents

Publication Publication Date Title
EP0529234A3 (fr)
EP0530988A3 (fr)
EP0512225A3 (fr)
DE4291050T1 (fr)
DE4291684T1 (fr)
EP0529093A4 (fr)
EP0503606A3 (fr)
DE4290056T1 (fr)
EP0528051A4 (fr)
EP0501430A3 (fr)
DE4292012T1 (fr)
TW282402B (fr)
ECSM91533U (fr)
ECSM91545U (fr)
EP0508059A3 (fr)
EP0512826A3 (fr)
CN3009748S (fr)
EP0497360A3 (fr)
EP0500398A3 (fr)
CN3008237S (fr)
EP0501617A3 (fr)
EP0502497A3 (fr)
AU8689191A (fr)
EP0507384A3 (fr)
AU8476191A (fr)